IPP Bureau
Glycomine completes enrollment in Phase 2b trial for rare genetic disorder
By IPP Bureau - April 10, 2026
The study is a global, randomized, double-blind, placebo-controlled trial testing GLM101 for phosphomannomutase 2 congenital disorder of glycosylation
Zeto gains FDA nod for new outpatient EEG system promising faster brain health testing
By IPP Bureau - April 10, 2026
The FDA clearance of Zeto New Wave marks the company’s third cleared device, alongside Zeto WR19 and Zeto ONE
Beacon raises $132M+ to bring AI-driven sleep diagnostics to masses
By IPP Bureau - April 10, 2026
The device aims to bring precision neuroscience into clinical trials, accelerating drug development
VDYNE gets FDA nod to launch pivotal US trial for tricuspid valve device
By IPP Bureau - April 10, 2026
The approval clears the way for a US study at leading clinical centers to evaluate the safety and effectiveness of VDYNE’s system in patients
Actinium Pharma unveils groundbreaking data on radiotherapy platform at AACR 2026
By IPP Bureau - April 10, 2026
The presentations will showcase previously undisclosed data highlighting the expanding potential of Actinium’s Ac-225 radiotherapy platform across both solid tumors and hematologic malignancies
Lupin Foundation expands NCD care access in Rajasthan with new diagnostic corners
By IPP Bureau - April 10, 2026
The initiative is aimed at strengthening the district-level screening and chronic disease management infrastructure
Plasmidsaurus expands RNA-Seq in Europe, partners with Genovis for ambient RNA shipping
By IPP Bureau - April 10, 2026
The dual expansion simplifies transcriptomics workflows by combining faster regional turnaround with easier sample logistics
SS Innovations unveils battlefield surgery drone system and mobile OR platform at SMRSC 2026
By IPP Bureau - April 10, 2026
The biggest highlight was Project Vimana, a drone-deployed battlefield trauma surgery system engineered to bring life-saving surgical intervention
Experts seek insurance coverage for stroke rehabilitation as recovery costs rise
By IPP Bureau - April 10, 2026
Experts also underscored the growing role of technologies such as tele-neurorehabilitation, robotics, and AI-driven therapies in improving recovery outcomes
Union Health Secretary reviews Swachhata Pakhwada at AIIMS Mangalagiri
By IPP Bureau - April 10, 2026
Punya Salila Srivastava commends sanitation, waste management and infection control measures, while inaugurating a new G+9 undergraduate girls’ hostel
WCD Ministry launches 8th Poshan Pakhwada 2026 with focus on early brain development
By IPP Bureau - April 10, 2026
The nationwide campaign, running from April 9–23 highlights the first 1,000 days, nutrition, responsive caregiving and play-based learning as critical pillars for children
Biocon appoints Mandar Ghatnekar as Chief Technology Officer
By IPP Bureau - April 10, 2026
Former Global Head of IT & Digital Transformation at Biocon Biologics steps into enterprise-wide technology leadership role
Aniruddha Rajurkar appointed as CEO of Zenex Animal Health
By IPP Bureau - April 10, 2026
In his new role, he is expected to further strengthen Zenex Animal Health’s market position and accelerate its next phase of growth.
Cadila Pharma launches triple-combination therapy for stronger BP control
By IPP Bureau - April 10, 2026
The new single-pill therapy combines cilnidipine, telmisartan and metoprolol, bringing together three established antihypertensive agents with complementary mechanisms
Fortis appoints Lokesh Taridalu Shivakumar as Facility Director for Yeshwanthapur hospital
By IPP Bureau - April 10, 2026
The leading hospital chain appoints Lokesh Taridalu Shivakumar as Facility Director for Yeshwanthapur hospital
